Clinical Trials Logo
  1. Home
  2. Anemia
  3. NCT06198790
  4. Details
NCT06198790 Clinical Trial

Postoperative Anemia After Bariatric Surgery

Anemia Clinical Trial

Official title:
Postoperative Anemia After Bariatric Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06198790
Other study ID # CJBariatric005
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2024
Est. completion date December 31, 2027

Study information
Verified date January 2024
Source China-Japan Friendship Hospital
Contact Yuntao Nie, M.D.
Phone +8618611835860
Email nytnyt1231@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To investigate the real incidence of short and long-term anemia after bariatric surgery, and explore the risk factors.

Description:

This study aims to investigate the real incidence of short and long-term anemia after bariatric surgery and explore the risk factors.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 400
Est. completion date December 31, 2027
Est. primary completion date December 31, 2026
Accepts healthy volunteers
Gender All
Age group 16 Years to 70 Years
Eligibility Inclusion Criteria: - Patients who will undergo sleeve gastrectomy or Roux-en-Y gastric bypass - Aged between 16 and 70 years - Patients who is not diagnosed as anemia at baseline Exclusion Criteria: - Patients who have anemia at baseline

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Yuntao Nie Beijing

Sponsors (1)
Lead Sponsor Collaborator
China-Japan Friendship Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Incidence of anemia after 1, 3, 5, 10 years Incidence of anemia after 1, 3, 5, 10 years 10 years
Secondary Incidence of anemia-related nutrient deficiencies Incidence of folate, ferritin, vitamin B12, and iron deficiencies 10 years
Secondary Hazard ratios for the risk factors of postoperative anemia Hazard ratios for the risk factors of postoperative anemia will be calculated by Cox regression model. 10 years
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Terminated NCT01535781 - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? N/A
Completed NCT01458028 - Age and Gender Effects on the Pharmacokinetics of BAY85-3934 Phase 1